Research Funding Priorities

The Susan Poorman Blackie Ovarian Cancer Foundation is dedicated to funding innovative research that will change the way ovarian cancer is detected and treated.

Without a reliable screening tool, and because symptoms can be vague or easily attributed to something else, only 20% of women are diagnosed with ovarian cancer at an early stage. Early detection is critical because when ovarian cancer is found early at a localized stage, approximately 94% of patients live longer than 5 years after diagnosis.

Susan Poorman Blackie Ovarian Cancer Foundation focuses on funding promising research on early detection that will lead to a standardized screening test as well as funding innovative research to rapidly develop effective treatment options including targeted therapy, immunotherapy, gene therapy, and personalized treatment protocols.

We believe this will help increase survival rates for women impacted by this deadly disease, make ovarian cancer a treatable disease, and eventually find a cure.